Your browser doesn't support javascript.
loading
Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen.
Rytting, Michael E; Jabbour, Elias J; Jorgensen, Jeffrey L; Ravandi, Farhad; Franklin, Anna R; Kadia, Tapan M; Pemmaraju, Naveen; Daver, Naval G; Ferrajoli, Alessandra; Garcia-Manero, Guillermo; Konopleva, Marina Y; Borthakur, Gautam; Garris, Rebecca; Wang, Sa; Pierce, Sherry; Schroeder, Kurt; Kornblau, Steven M; Thomas, Deborah A; Cortes, Jorge E; O'Brien, Susan M; Kantarjian, Hagop M.
Afiliación
  • Rytting ME; Pediatrics-Patient Care, the University of Texas MD Anderson Cancer Center, Texas.
  • Jabbour EJ; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Texas.
  • Jorgensen JL; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Texas.
  • Ravandi F; Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Texas.
  • Franklin AR; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Texas.
  • Kadia TM; Pediatrics-Patient Care, the University of Texas MD Anderson Cancer Center, Texas.
  • Pemmaraju N; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Texas.
  • Daver NG; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Texas.
  • Ferrajoli A; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Texas.
  • Garcia-Manero G; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Texas.
  • Konopleva MY; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Texas.
  • Borthakur G; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Texas.
  • Garris R; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Texas.
  • Wang S; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Texas.
  • Pierce S; Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Texas.
  • Schroeder K; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Texas.
  • Kornblau SM; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Texas.
  • Thomas DA; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Texas.
  • Cortes JE; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Texas.
  • O'Brien SM; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Texas.
  • Kantarjian HM; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Texas.
Am J Hematol ; 91(8): 819-23, 2016 08.
Article en En | MEDLINE | ID: mdl-27178680
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Am J Hematol Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Am J Hematol Año: 2016 Tipo del documento: Article